Astragaloside IV attenuates ferroptosis-related testicular injury in rats with experimental varicocele. [PDF]
Gao B +6 more
europepmc +1 more source
Redefining the mCRPC frontline: lessons from PEACE-3 and BRCAaway in the post-ARPI era. [PDF]
Banna GL +3 more
europepmc +1 more source
Abiraterone or Enzalutamide for Patients With Metastatic Castration-Sensitive Prostate Cancer: A Nationwide Veterans Affairs Study. [PDF]
La J +7 more
europepmc +1 more source
Matching-adjusted indirect comparison of enzalutamide versus apalutamide with androgen-deprivation therapy in patients with metastatic hormone-sensitive prostate cancer. [PDF]
Azad AA +9 more
europepmc +1 more source
Androgen receptor-regulated ZNF419 modulates ferroptosis sensitivity via the ZDHHC20-GPX4 pathway in prostate cancer. [PDF]
Hou Y +9 more
europepmc +1 more source
Enzalutamide promotes an early plasticity-associated transcriptional state without terminal neuroendocrine differentiation in prostate cancer cells. [PDF]
Watanabe R +5 more
europepmc +1 more source
How enzalutamide affects sex life and how taking a break from treatment affects quality of life: a plain language summary of results from the EMBARK study in people with hormone-sensitive prostate cancer and high-risk biochemical recurrence. [PDF]
Freedland SJ +11 more
europepmc +1 more source
WSB1-Mediated PSMA Ubiquitination Promotes Enzalutamide-Induced Neuroendocrine-like Transition in Patient-Derived Prostate Cancer Spheroids. [PDF]
Jung D +14 more
europepmc +1 more source
Beyond androgen deprivation therapy: Next-generation hormonal therapies and emerging combination approaches in advanced prostate cancer. [PDF]
Paras G, Schweizer MT.
europepmc +1 more source

